Research a compound stack end to end — a structured protocol scaffold, how VialTalk researchers actually combine these compounds, receptor conflicts, and live COA-verified prices. Add 1–5 compounds.
Research signals
Redundancy, true conflicts, and dangerous additive effects
Conflicts found
1 flagged interaction found
Receptor activity map
| Receptor | Retatrutide | GHK-Cu | Tirzepatide | KPV |
|---|---|---|---|---|
| GLP-1R (GLP1R, P43220) | ||||
| GIPR (P48546) | ||||
| Glucagon receptor (GCGR, P47871) | ||||
| NF-κB / p65RelA nuclear import pathway | ||||
| Extracellular matrix / MMP / collagen synthesis axis | ||||
| Melanocortin receptor system (MC1R/MC3R/MC4R) |
A structured, research-grounded protocol for this stack
Sign in to build a structured research protocol scaffold for KPV + Tirzepatide + GHK-Cu + Retatrutide — phases, per-compound parameters, endpoints and washout, grounded in documented research.
What VialTalk researchers actually run
No researchers have logged this exact combination yet — yours could be the first.
Researchers are also adding
Best price for each compound today
Same “From” price shown on each compound's page (after discounts). Panels = COA assays tested. Tap “Compare all vendors” for the full breakdown.
For research and informational use only. VialTalk does not provide medical advice or dosing guidance. Community data reflects self-reported public research journals.